Who owns the RIBAI trademark?

The RIBAI trademark is owned by Actinium Pharmaceuticals, Inc..

What is the serial number for RIBAI?

The USPTO serial number for RIBAI is 99632186.

What is the registration number for RIBAI?

RIBAI is registered under USPTO registration number 0.

RIB

USPTO Trademark Record

PENDING

RIBAI

Q: What class is the RIBAI trademark registered in?

The RIBAI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 99632186·Reg 0·Filed Feb 03, 2026

Owner Actinium Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

RIBAI (Serial No. 99632186), Registration No. 0, is a pending US trademark filed on Feb 03, 2026 by Actinium Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Office Action response: December 01, 202643 days remaining

Mark Intelligence

RIBAI (Reg. #0) is a pending US trademark that was filed in 2026 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Feb 03, 2026

SERIAL

99632186

REG#

Owner

Applicant

Actinium Pharmaceuticals, Inc.

Entity

Corporation

State

Address

100 Park Avenue 23rd Floor, New York, NY, 10017

Country

Attorney

NameMichael E. Dukes

Law firm

Michael E. Dukes Dentons Cohen & Grigsby, P.C.

Docket

TM25-106

Address

625 Liberty Ave., Pittsburgh, PA 15222, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateFeb 03, 2026

Serial Number99632186

Registration No.0

Status DateJun 01, 2026

Mark TypeStandard characters

Attorney DocketTM25-106

Status DescriptionLive and pending, non-final action mailed

Filing Signals

FILED

2026

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

9 events

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Sep 01, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Sep 01, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

ASSIGNED TO EXAMINER

Jun 01, 2026

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jun 01, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 01, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 01, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 29, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 03, 2026

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 03, 2026

APPLICATION FILING RECEIPT MAILED

RIBAI

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Actinium Pharmaceuticals, Inc.

Other Marks by Michael E. Dukes

Resources

Company